← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Ubiquitx, Inc.
New York, NY
$1,634,696
Total funding
5
Grants
Funding over time
peak $888.3K · FY2023–25$1M$750K$500K$250K$0
'23
'24
'25
Funding mix
By agency
NIH$1,359,696 · 4
NSF$275,000 · 1
By mechanism
R41$613,293 · 2
R43$391,495 · 1
N43$354,908 · 1
—$275,000 · 1
Investigators at Ubiquitx, Inc.
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Emerging Leaders
6–10 yrs in
Not enough data
All-Time
Most funded here, all years
Largest grants
Chimeric Ligands for Induced Proximity (CLIP) platform for targeted proteome editing to treat severe alcoholic hepatitis$391,495
R43 · FY2025 · AA
UBIQUIBODY PLATFORM FOR TARGETED DEGRADATION OF ONCOGENIC FUSION PROTEINS$354,908
N43 · FY2023 · CA
Computational design and evaluation of peptide-guided protein degraders$306,872
R41 · FY2024 · GM
Chimeric Ligands for Induced Proximity (CLIP) platform for targeted proteome editing and upregulation of antigen presentation$299,921
R41 · FY2024 · AI
SBIR Phase I: Chimeric Ligands for Induced Proximity (CLIPs) for Targeted Proteome Editing$275,000
· FY2024 · TIP
Computational design and evaluation of peptide-guided protein degraders$6,500
R41 · FY2024 · GM